Seamless Phase I--II Cancer Clinical Trials Using Kernel-Based Covariate Similarity
Kana Makino, Natsumi Makigusa, Masahiro Kojima

TL;DR
This paper introduces a kernel-based adaptive borrowing method for seamless Phase I/II cancer trials, improving efficacy assessment by leveraging covariate similarity between phases.
Contribution
It develops a nonparametric, covariate-adaptive borrowing approach using kernel-based MMD for early-phase oncology trial design, enhancing data reuse and efficacy evaluation.
Findings
Improved probability of correctly identifying efficacious doses.
Avoided false positives at weakly efficacious doses.
Demonstrated effectiveness through simulation and a case study.
Abstract
In response to the U.S.\ Food and Drug Administration's (FDA) Project Optimus, a paradigm shift is underway in the design of early-phase oncology trials. To accelerate drug development, seamless Phase I/II designs have gained increasing attention, along with growing interest in the efficient reuse of Phase I data. We propose a nonparametric information-borrowing method that adaptively discounts Phase I observations according to the similarity of covariate distributions between Phase I and Phase II. Similarity is quantified using a kernel-based maximum mean discrepancy (MMD) and transformed into a dose-specific weight incorporated into a power-prior framework for Phase II efficacy evaluation, such as for the objective response rate (ORR). Considering the small sample sizes typical of early-phase oncology studies, we analytically derive a confidence interval for the weight, enabling…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials · Advanced Causal Inference Techniques · Optimal Experimental Design Methods
